Quick Answer
Lipocine Inc. reported Total Assets of $17.01 million for the year ending 2025.
- Lipocine Inc. showed a decrease of -24.5% in Total Assets from 2024 to 2025.
- This data is from Lipocine Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $622.00 | Q1 2013: $458.00 | Q2 2013: $10.00 | Q3 2013: $37.17 million | Q1 2014: $42.10 million | Q2 2014: $35.49 million | Q3 2014: $32.02 million | Q1 2015: $25.06 million | Q2 2015: $53.80 million | Q3 2015: $48.43 million | Q1 2016: $38.77 million | Q2 2016: $33.35 million | Q3 2016: $29.55 million | Q1 2017: $27.22 million | Q2 2017: $28.05 million | Q3 2017: $26.26 million | Q1 2018: $31.68 million | Q2 2018: $25.30 million | Q3 2018: $22.69 million | Q1 2019: $22.99 million | Q2 2019: $19.68 million | Q3 2019: $17.34 million | Q1 2020: $20.99 million | Q2 2020: $23.49 million | Q3 2020: $24.75 million | Q1 2021: $50.58 million | Q2 2021: $47.18 million | Q3 2021: $40.39 million | Q1 2022: $47.60 million | Q2 2022: $42.19 million | Q3 2022: $39.42 million | Q1 2023: $34.02 million | Q2 2023: $30.48 million | Q3 2023: $24.75 million | Q1 2024: $25.45 million | Q2 2024: $23.03 million | Q3 2024: $20.70 million | Q1 2025: $20.50 million | Q2 2025: $18.58 million | Q3 2025: $16.07 million.
- Over the full 15 years of available data (2011 to 2025), Lipocine Inc.'s Total Assets has grown by 52,316.9%.
- Historical annual values: Fiscal year 2025: $17.01 million | Fiscal year 2024: $22.51 million | Fiscal year 2023: $23.00 million | Fiscal year 2022: $37.54 million | Fiscal year 2021: $52.48 million | Fiscal year 2020: $25.35 million | Fiscal year 2019: $19.66 million | Fiscal year 2018: $20.85 million | Fiscal year 2017: $25.33 million | Fiscal year 2016: $27.34 million | Fiscal year 2015: $45.38 million | Fiscal year 2014: $27.99 million | Fiscal year 2013: $46.11 million | Fiscal year 2012: $5.57 million | Fiscal year 2011: $32.4 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: